280 related articles for article (PubMed ID: 34725790)
1. Pluripotency Stemness and Cancer: More Questions than Answers.
Hatina J; Kripnerová M; Houdek Z; Pešta M; Tichánek F
Adv Exp Med Biol; 2022; 1376():77-100. PubMed ID: 34725790
[TBL] [Abstract][Full Text] [Related]
2. Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.
Hawkins KE; Moschidou D; Faccenda D; Wruck W; Martin-Trujillo A; Hau KL; Ranzoni AM; Sanchez-Freire V; Tommasini F; Eaton S; De Coppi P; Monk D; Campanella M; Thrasher AJ; Adjaye J; Guillot PV
Mol Ther; 2017 Feb; 25(2):427-442. PubMed ID: 28153093
[TBL] [Abstract][Full Text] [Related]
3. H1FOO-DD promotes efficiency and uniformity in reprogramming to naive pluripotency.
Kunitomi A; Hirohata R; Osawa M; Washizu K; Arreola V; Saiki N; Kato TM; Nomura M; Kunitomi H; Ohkame T; Ohkame Y; Kawaguchi J; Hara H; Kusano K; Yamamoto T; Takashima Y; Tohyama S; Yuasa S; Fukuda K; Takasu N; Yamanaka S
Stem Cell Reports; 2024 May; 19(5):710-728. PubMed ID: 38701780
[TBL] [Abstract][Full Text] [Related]
4. Complex haploinsufficiency in pluripotent cells yields somatic cells with DNA methylation abnormalities and pluripotency induction defects.
Lasry R; Maoz N; Cheng AW; Yom Tov N; Kulenkampff E; Azagury M; Yang H; Ople C; Markoulaki S; Faddah DA; Makedonski K; Orzech D; Sabag O; Jaenisch R; Buganim Y
Stem Cell Reports; 2023 Nov; 18(11):2174-2189. PubMed ID: 37832543
[TBL] [Abstract][Full Text] [Related]
5. Expression and Functional Analysis of core stemness factors OSKM (OCT4, SOX2, KLF4, and MYC) in Pan-cancer.
Hong L; Hong S; Zhang X
Medicine (Baltimore); 2023 Dec; 102(48):e36433. PubMed ID: 38050242
[TBL] [Abstract][Full Text] [Related]
6. Profiling the role of m6A effectors in the regulation of pluripotent reprogramming.
Wang W; Zhou L; Li H; Sun T; Wen X; Li W; Esteban MA; Hoffman AR; Hu JF; Cui J
Hum Genomics; 2024 Apr; 18(1):33. PubMed ID: 38566168
[TBL] [Abstract][Full Text] [Related]
7. Oct4 redox sensitivity potentiates reprogramming and differentiation.
Shen Z; Wu Y; Manna A; Yi C; Cairns BR; Evason KJ; Chandrasekharan MB; Tantin D
Genes Dev; 2024 May; 38(7-8):308-321. PubMed ID: 38719541
[TBL] [Abstract][Full Text] [Related]
8. Pluripotency-independent induction of human trophoblast stem cells from fibroblasts.
Naama M; Rahamim M; Zayat V; Sebban S; Radwan A; Orzech D; Lasry R; Ifrah A; Jaber M; Sabag O; Yassen H; Khatib A; Epsztejn-Litman S; Novoselsky-Persky M; Makedonski K; Deri N; Goldman-Wohl D; Cedar H; Yagel S; Eiges R; Buganim Y
Nat Commun; 2023 Jun; 14(1):3359. PubMed ID: 37291192
[TBL] [Abstract][Full Text] [Related]
9.
Kumar S; De Leon EM; Granados J; Whitworth DJ; VandeBerg JL
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293487
[TBL] [Abstract][Full Text] [Related]
10. Regulatory Elements Outside Established
Ermakova VV; Fokin NP; Aksenov ND; Bakhmet EI; Aleksandrova EV; Kuzmin AA; Tomilin AN
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895112
[TBL] [Abstract][Full Text] [Related]
11. Complex regulatory networks influence pluripotent cell state transitions in human iPSCs.
Arthur TD; Nguyen JP; D'Antonio-Chronowska A; Matsui H; Silva NS; Joshua IN; ; Luchessi AD; Greenwald WWY; D'Antonio M; Pera MF; Frazer KA
Nat Commun; 2024 Feb; 15(1):1664. PubMed ID: 38395976
[TBL] [Abstract][Full Text] [Related]
12. A short history of pluripotent stem cells markers.
Andrews PW; Gokhale PJ
Stem Cell Reports; 2024 Jan; 19(1):1-10. PubMed ID: 38157849
[TBL] [Abstract][Full Text] [Related]
13. Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood.
Szablowska-Gadomska I; Sypecka J; Zayat V; Podobinska M; Pastwinska A; Pienkowska-Grela B; Buzanska L
Acta Neurobiol Exp (Wars); 2012; 72(4):337-50. PubMed ID: 23377265
[TBL] [Abstract][Full Text] [Related]
14. FACT Inhibition Blocks Induction But Not Maintenance of Pluripotency.
Shen Z; Formosa T; Tantin D
Stem Cells Dev; 2018 Dec; 27(24):1693-1701. PubMed ID: 30319048
[TBL] [Abstract][Full Text] [Related]
15. Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells.
Lin YC; Ku CC; Wuputra K; Liu CJ; Wu DC; Satou M; Mitsui Y; Saito S; Yokoyama KK
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791215
[TBL] [Abstract][Full Text] [Related]
16. Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells.
Yang F; Cui P; Lu Y; Zhang X
Stem Cell Res Ther; 2019 Aug; 10(1):233. PubMed ID: 31375149
[TBL] [Abstract][Full Text] [Related]
17. Minireview: the diverse roles of nuclear receptors in the regulation of embryonic stem cell pluripotency.
Wagner RT; Cooney AJ
Mol Endocrinol; 2013 Jun; 27(6):864-78. PubMed ID: 23504955
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis.
Heo J; Noh BJ; Lee S; Lee HY; Kim Y; Lim J; Ju H; Yu HY; Ryu CM; Lee PC; Jeong H; Oh Y; Kim K; Kim SY; Son J; Hong B; Kim JS; Cho YM; Shin DM
EMBO Mol Med; 2020 Jan; 12(1):e10880. PubMed ID: 31709755
[TBL] [Abstract][Full Text] [Related]
19. Influence of low oxygen tensions on expression of pluripotency genes in stem cells.
Szablowska-Gadomska I; Zayat V; Buzanska L
Acta Neurobiol Exp (Wars); 2011; 71(1):86-93. PubMed ID: 21499329
[TBL] [Abstract][Full Text] [Related]
20. Trans-spliced long non-coding RNA: an emerging regulator of pluripotency.
Yu CY; Chuang CY; Kuo HC
Cell Mol Life Sci; 2018 Sep; 75(18):3339-3351. PubMed ID: 29961157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
